Plausible link between Johnson & Johnson vaccine and rare blood clotting but overall risk low

Patients with the rare but serious disorder develop both blood clots, often in the brain, and low levels of platelets, blood components that promote clotting. The disorder is a “rare, clinically serious and potentially life-threatening condition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3f97kWI
via IFTTT